Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 182.
Article
Abbas, A;
Tabish, TA;
Bull, SJ;
Lim, TM;
Phan, AN;
(2020)
High yield synthesis of graphene quantum dots from biomass waste as a highly selective probe for Fe3+ sensing.
Scientific Reports
, 10
, Article 21262. 10.1038/s41598-020-78070-2.
|
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
Agbuduwe, C;
Yang, H;
Gaglani, J;
Ajithkumar, T;
(2020)
Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK.
Clinical Medicine Journal
, 20
(5)
e191-e195.
10.7861/clinmed.2019-0488.
|
Agbuduwe, C;
Basu, S;
(2020)
Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy.
European Journal of Haematology
10.1111/ejh.13491.
(In press).
|
Ahmed, J;
Tabish, TA;
Zhang, S;
Edirisinghe, M;
(2020)
Porous Graphene Composite Polymer Fibres.
Polymers
, 13
(1)
, Article 76. 10.3390/polym13010076.
|
Aitken, J;
Ambrose, K;
Barrell, S;
Beale, R;
Bineva-Todd, G;
Biswas, D;
Byrne, R;
... Wu, M; + view all
(2020)
Scalable and robust SARS-CoV-2 testing in an academic center.
Nature Biotechnology
, 38
(8)
pp. 927-931.
10.1038/s41587-020-0588-y.
|
Ali, A;
Plus 12 other authors, TPUWPO;
Sydes, M;
Clarke, NW;
(2020)
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”.
European Urology Oncology
, 3
(4)
pp. 412-419.
10.1016/j.euo.2020.05.003.
|
Alwan, NA;
Burgess, RA;
Ashworth, S;
Beale, R;
Bhadelia, N;
Bogaert, D;
Dowd, J;
... Ziauddeen, H; + view all
(2020)
Scientific consensus on the COVID-19 pandemic: we need to act now.
The Lancet
, 396
(10260)
e71-e72.
10.1016/S0140-6736(20)32153-X.
|
Amir, A;
Porwal, H;
Mahalingam, S;
Wu, X;
Wu, T;
Chen, B;
Tabish, TA;
(2020)
Microstructure of fibres pressure-spun from polyacrylonitrile – graphene oxide composite mixtures.
Composites Science and Technology
, 197
, Article 108214. 10.1016/j.compscitech.2020.108214.
|
An, Z;
Flores-Borja, F;
Irshad, S;
Deng, J;
Ng, T;
(2020)
Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer.
Frontiers in Immunology
, 10
, Article 3111. 10.3389/fimmu.2019.03111.
|
Anderton, J;
Moroz, V;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Brennan, B; + view all
(2020)
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Trials
, 21
(1)
, Article 96. 10.1186/s13063-019-4026-8.
|
Argiles, G;
Tabernero, J;
Labianca, R;
Hochhauser, D;
Salazar, R;
Iveson, T;
Laurent-Puig, P;
... ESMO Guidelines Committee; + view all
(2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 31
(10)
pp. 1291-1305.
10.1016/j.annonc.2020.06.022.
|
Azad, AK;
Zhabyeyev, P;
Vanhaesebroeck, B;
Eitzen, G;
Oudit, GY;
Moore, RB;
Murray, AG;
(2020)
Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth.
Oncogene
, 39
pp. 6480-6492.
10.1038/s41388-020-01444-3.
|
Bahleda, R;
Meric-Bernstam, F;
Goyal, L;
Tran, B;
He, Y;
Yamamiya, I;
Benhadji, KA;
... Arkenau, H-T; + view all
(2020)
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors.
Annals of Oncology
10.1016/j.annonc.2020.06.018.
(In press).
|
Bailey, C;
Black, JRM;
Swanton, C;
(2020)
Cancer Research: The Lessons to Learn from COVID-19.
Cancer Discovery
, 10
(9)
pp. 1263-1266.
10.1158/2159-8290.CD-20-0823.
|
Bailey, C;
Shoura, MJ;
Mischel, PS;
Swanton, C;
(2020)
Extrachromosomal DNA d relieving heredity constraints, accelerating tumour evolution.
Annals of Oncology
, 31
(7)
pp. 884-893.
10.1016/j.annonc.2020.03.303.
|
Banerjee, S;
Tovey, H;
Bowen, R;
Folkerd, E;
Kilburn, L;
McLachlan, J;
Hall, M;
... Bliss, JM; + view all
(2020)
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK-A16037).
Therapeutic Advances in Medical Oncology
, 12
, Article ARTN 175. 10.1177/1758835920975352.
|
Bartlett, JMS;
Bayani, J;
Kornaga, EN;
Danaher, P;
Crozier, C;
Piper, T;
Yao, CQ;
... Stein, RC; + view all
(2020)
Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
PLOS ONE
, 15
(9)
, Article e0238593. 10.1371/journal.pone.0238593.
|
Bell, R;
Kirkwood, A;
Hargrave, D;
Michalski, A;
Hyare, H;
Jacques, T;
Stoneham, S;
... Shankar, A; + view all
(2020)
Disseminated Low Grade Glioma in Children and Young Adults.
ARC Journal of Cancer Science
, 6
(1)
pp. 7-18.
10.20431/2455-6009.0601002.
|
Birkbak, NJ;
McGranahan, N;
(2020)
Cancer Genome Evolutionary Trajectories in Metastasis.
Cancer Cell
, 37
(1)
pp. 8-19.
10.1016/j.ccell.2019.12.004.
|
Black, JRM;
Bailey, C;
Przewrocka, J;
Dijkstra, KK;
Swanton, C;
(2020)
COVID-19: the case for health-care worker screening to prevent hospital transmission.
The Lancet
, 395
(10234)
pp. 1418-1420.
10.1016/S0140-6736(20)30917-X.
|
Blagih, J;
Zani, F;
Chakravarty, P;
Hennequart, M;
Pilley, S;
Hobor, S;
Hock, AK;
... Vousden, KH; + view all
(2020)
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.
Cell Reports
, 30
(2)
481-496.e6.
10.1016/j.celrep.2019.12.028.
|
Bono, P;
Massard, C;
Peltola, KJ;
Azaro, A;
Italiano, A;
Kristeleit, RS;
Curigliano, G;
... Rodon, JA; + view all
(2020)
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.
ESMO Open
, 5
(6)
, Article e001081. 10.1136/esmoopen-2020-001081.
|
Brocklebank, V;
Kumar, G;
Howie, AJ;
Chandar, J;
Milford, DV;
Craze, J;
Evans, J;
... Kavanagh, D; + view all
(2020)
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.
Kidney International
, 97
(6)
pp. 1260-1274.
10.1016/j.kint.2020.01.045.
|
Carmona Echeverria, LM;
Haider, A;
Freeman, A;
Stopka-Farooqui, U;
Rosenfeld, A;
Simpson, BS;
Hu, Y;
... Whitaker, HC; + view all
(2020)
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Scientific Reports
, 10
, Article 17177. 10.1038/s41598-020-73524-z.
|
Carter, TJ;
Milic, M;
McDerra, J;
McTiernan, A;
Ahmed, M;
Karavasilis, V;
Michelagnoli, M;
... Strauss, SJ; + view all
(2020)
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.
Cancers
, 12
(11)
, Article 3408. 10.3390/cancers12113408.
|
Casiraghi, N;
Orlando, F;
Ciani, Y;
Xiang, J;
Sboner, A;
Elemento, O;
Attard, G;
... Romanel, A; + view all
(2020)
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA.
Bioinformatics
, 36
(9)
pp. 2665-2674.
10.1093/bioinformatics/btaa016.
|
Chambers, P;
Man, KKC;
Lui, VWY;
Mpima, S;
Nasuti, P;
Forster, MD;
Wong, ICK;
(2020)
Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.
JCO Precision Oncology
, 16
(8)
e770-e778.
10.1200/JOP.19.00507.
|
Chau, I;
Penel, N;
Soriano, AO;
Arkenau, HT;
Cultrera, J;
Santana-Davila, R;
Calvo, E;
... Fuchs, CS; + view all
(2020)
Ramucirumab in combination with pembrolizumab in treatment-naïve advanced gastric or gej adenocarcinoma: Safety and antitumor activity from the phase 1a/b jvdf trial.
Cancers
, 12
(10)
, Article 2985. 10.3390/cancers12102985.
|
Chugh, R;
Ballman, KV;
Helman, LJ;
Patel, S;
Whelan, JS;
Widemann, B;
Lu, Y;
... Strauss, SJ; + view all
(2020)
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
10.1002/cncr.33349.
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... STAMPEDE investigators; + view all
(2020)
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.
[Corrigendum].
Annals of Oncology
, 31
(3)
p. 442.
10.1016/j.annonc.2020.01.002.
|
Colomba, A;
Fitzek, M;
George, R;
Weitsman, G;
Roberts, S;
Zanetti-Domingues, L;
Hirsch, M;
... Parker, PJ; + view all
(2020)
A small molecule inhibitor of HER3: a proof-of-concept study.
Biochemical Journal
, 477
(17)
pp. 3329-3347.
10.1042/BCJ20200496.
|
Conduit, SE;
Davies, EM;
Ooms, LM;
Gurung, R;
McGrath, MJ;
Hakim, S;
Cottle, DL;
... Mitchell, CA; + view all
(2020)
AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
Human Molecular Genetics
, 29
(1)
pp. 31-48.
10.1093/hmg/ddz232.
|
Conduit, SE;
Vanhaesebroeck, B;
(2020)
Phosphoinositide lipids in primary cilia biology.
Biochemical Journal
, 477
(18)
pp. 3541-3565.
10.1042/BCJ20200277.
|
Corbett, S;
Huang, S;
Zammarchi, F;
Howard, PW;
van Berkel, PH;
Hartley, JA;
(2020)
The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates.
Molecular Cancer Therapeutics
, 19
(9)
pp. 1856-1865.
10.1158/1535-7163.MCT-20-0222.
|
Craig, Z;
Swain, J;
Batman, E;
Wadsley, J;
Reed, N;
Faluyi, O;
Cave, J;
... McNamara, MG; + view all
(2020)
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC).
BMJ Open
, 10
(2)
, Article e034527. 10.1136/bmjopen-2019-034527.
|
Crolley, VE;
Hanna, D;
Joharatnam-Hogan, N;
Chopra, N;
Bamac, E;
Desai, M;
Lam, YC;
... Khan, K; + view all
(2020)
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Therapeutic Advances in Medical Oncology
, 12
pp. 1-14.
10.1177/1758835920971147.
|
Crolley, VE;
Marashi, H;
Rawther, S;
Sirohi, B;
Parton, M;
Graham, J;
Vinayan, A;
... King, J; + view all
(2020)
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Breast Cancer Research and Treatment
, 180
pp. 809-817.
10.1007/s10549-020-05578-6.
|
Davidson, B;
Gurusamy, K;
Corrigan, N;
Croft, J;
Ruddock, S;
Pullan, A;
Brown, J;
... de Wilt, JH; + view all
(2020)
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Health Technology Assessment
, 24
(21)
10.3310/hta24210.
|
Davis, LauraMay;
Smith, April-Louise;
Aldridge, Matthew D;
Foulkes, Jack;
Peet, Connie;
Wan, Simon;
Gains, Jennifer E;
... Gaze, Mark N; + view all
(2020)
Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics.
Journal of Personalized Medicine
, 10
(4)
, Article 174. 10.3390/jpm10040174.
|
de Greef, PC;
Oakes, T;
Gerritsen, B;
Ismail, M;
Heather, JM;
Hermsen, R;
Chain, B;
(2020)
The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes.
eLife
, 9
, Article e49900. 10.7554/eLife.49900.
|
DeGregori, James;
Pharoah, Paul;
Sasieni, Peter;
Swanton, Charles;
(2020)
Cancer Screening, Surrogates of Survival, and the Soma.
Cancer Cell
, 38
(4)
pp. 433-437.
10.1016/j.ccell.2020.09.003.
|
Desai, R;
East, DA;
Hardy, L;
Faccenda, D;
Rigon, M;
Crosby, J;
Alvarez, MS;
... Campanella, M; + view all
(2020)
Mitochondria form contact sites with the nucleus to couple prosurvival retrograde response.
Science Advances
, 6
(51)
, Article eabc9955. 10.1126/sciadv.abc9955.
|
Drew, Y;
Kristeleit, RS;
Oaknin, A;
Ray-Coquard, I;
Haris, NM;
Swisher, EM;
(2020)
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
The Oncologist
, 25
(1)
e109-e119.
10.1634/theoncologist.2019-0229.
|
Drilon, A;
Siena, S;
Dziadziuszko, R;
Barlesi, F;
Krebs, MG;
Shaw, AT;
de Braud, F;
... Doebele, RC; + view all
(2020)
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
The Lancet Oncology
, 21
(2)
pp. 261-270.
10.1016/S1470-2045(19)30690-4.
|
Easom, NJW;
Marks, M;
Jobe, D;
Gillmore, R;
Meyer, T;
Maini, MK;
Njie, R;
(2020)
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome.
Frontiers in Oncology
, 10
, Article 971. 10.3389/fonc.2020.00971.
|
Faivre-Finn, C;
Fenwick, JD;
Franks, KN;
Harrow, S;
Hatton, MQF;
Hiley, C;
McAleese, JJ;
... Toy, E; + view all
(2020)
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.
Clinical Oncology
, 32
(8)
pp. 481-489.
10.1016/j.clon.2020.05.001.
|
Fennell, D;
Danson, S;
Woll, P;
Forster, M;
Talbot, D;
Child, J;
Farrelly, L;
... Wheeler, G; + view all
(2020)
Ganetespib in combination with pemetrexed-platinum chemotherapy in patients with pleural Mesothelioma (MESO-02): A phase Ib trial.
Clinical Cancer Research
, 26
(18)
pp. 4748-4755.
10.1158/1078-0432.CCR-20-1306.
|
Ferguson, MS;
Chard Dunmall, LS;
Gangeswaran, R;
Marelli, G;
Tysome, JR;
Burns, E;
Whitehead, MA;
... Wang, Y; + view all
(2020)
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.
Molecular Therapy
10.1016/j.ymthe.2020.02.017.
(In press).
|
Finn, RS;
Ikeda, M;
Zhu, AX;
Sung, MW;
Baron, AD;
Kudo, M;
Okusaka, T;
... Llovet, JM; + view all
(2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
Journal of Clinical Oncology
10.1200/JCO.20.00808.
(In press).
|
Fontana, E;
Arkenau, H-T;
(2020)
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities.
Cancer Treatment Reviews
, 88
, Article 102047. 10.1016/j.ctrv.2020.102047.
|
Fostea, RM;
Fontana, E;
Torga, G;
Arkenau, HT;
(2020)
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma.
Cancers
, 12
(9)
, Article 2599. 10.3390/cancers12092599.
|
Gadaleta, E;
Fourgoux, P;
Pirró, S;
Thorn, GJ;
Nelan, R;
Ironside, A;
Rajeeve, V;
... Chelala, C; + view all
(2020)
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer.
npj Breast Cancer
, 6
, Article 38. 10.1038/s41523-020-00182-9.
|
Gao, D;
Barber, PR;
Chacko, JV;
Kader Sagar, MA;
Rueden, CT;
Grislis, AR;
Hiner, MC;
(2020)
FLIMJ: An open-source ImageJ toolkit for fluorescence lifetime image data analysis.
PLoS One
, 15
(12)
, Article e0238327. 10.1371/journal.pone.0238327.
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
Gillessen, S;
Attard, G;
Beer, TM;
Beltran, H;
Bjartell, A;
Bossi, A;
Briganti, A;
... Omlin, A; + view all
(2020)
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
European Urology
10.1016/j.eururo.2020.01.012.
(In press).
|
Gilson, C;
Ingleby, F;
Gilbert, DC;
Parry, MA;
Atako, NB;
Ali, A;
Hoyle, A;
... Chowdhury, S; + view all
(2020)
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial.
JCO Precision Oncology
, 4
pp. 882-897.
10.1200/po.19.00388.
|
Gomez, V;
(2020)
Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.
Science Signaling
, 13
(652)
, Article eaax4585. 10.1126/scisignal.aax4585.
|
Gomez, V;
Mustapha, R;
Ng, K;
Ng, T;
(2020)
Radiation therapy and the innate immune response: clinical implications for immunotherapy approaches.
British Journal of Clinical Pharmacology
, 86
(9)
pp. 1726-1735.
10.1111/bcp.14351.
|
Goncalves, T;
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Collopy, LC;
Strauss, SJ;
Mittnacht, S;
(2020)
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
ACS Pharmacology & Translational Science
, 3
(6)
pp. 1253-1264.
10.1021/acsptsci.0c00125.
|
Gonzalez-Ericsson, P;
Stovgaard, ES;
Sua, LF;
Reisenbichler, E;
Kos, Z;
Carter, JM;
Michiels, S;
... Sanders, M; + view all
(2020)
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
The Journal of Pathology
, 250
(5)
pp. 667-684.
10.1002/path.5406.
|
Grieco, G;
Wang, T;
Delcorte, O;
Spourquet, C;
Janssens, V;
Strickaert, A;
Gaide Chevronnay, H;
... Pierreux, CE; + view all
(2020)
Vps34 PI 3-kinase controls thyroid hormone production by regulating thyroglobulin iodination, lysosomal proteolysis and tissue homeostasis.
Thyroid
, 30
(1)
pp. 133-146.
10.1089/thy.2019.0182.
|
Guillotin, D;
Taylor, AR;
Platé, M;
Mercer, PF;
Edwards, LM;
Haggart, R;
Miele, G;
... Chambers, RC; + view all
(2020)
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis.
Thorax
, 76
(1)
pp. 73-82.
10.1136/thoraxjnl-2020-214902.
|
Hamilton, NJI;
Lee, DDH;
Gowers, KHC;
Butler, CR;
Maughan, EF;
Jevans, B;
Orr, JC;
... Janes, SM; + view all
(2020)
Bioengineered airway epithelial grafts with mucociliary function based on collagen IV- and laminin-containing extracellular matrix scaffolds.
European Respiratory Journal
, 55
, Article 1901200. 10.1183/13993003.01200-2019.
|
Harrington, KJ;
Bhide, SA;
Forster, MD;
Good, JS;
Gunn, L;
Kong, A;
Melcher, AA;
... Wong, KH; + view all
(2020)
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.
Clinical Oncology
, 32
(8)
pp. 490-492.
10.1016/j.clon.2020.05.016.
|
Herbst, RS;
Arkenau, HT;
Bendell, J;
Arrowsmith, E;
Wermke, M;
Soriano, A;
Penel, N;
... Paz-Ares, L; + view all
(2020)
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.
Journal of Thoracic Oncology
, 16
(2)
pp. 289-298.
10.1016/j.jtho.2020.10.004.
|
Herbst, RS;
Garon, EB;
Kim, D-W;
Cho, BC;
Perez-Gracia, JL;
Han, J-Y;
Arvis, CD;
... Baas, P; + view all
(2020)
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1Positive, Advanced NonSmall-Cell Lung Cancer in the KEYNOTE-010 Study.
Journal of Clinical Oncology
, 38
(14)
pp. 1580-1590.
10.1200/JCO.19.02446.
|
Hiley, C;
Salem, A;
Batchelor, T;
McDonald, F;
Evison, M;
(2020)
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer.
Thorax
, 75
(3)
pp. 198-199.
10.1136/thoraxjnl-2019-214014.
|
Hong, DS;
Concin, N;
Vergote, I;
de Bono, JS;
Slomovitz, BM;
Drew, Y;
Arkenau, H-T;
... Coleman, RL; + view all
(2020)
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Clinical Cancer Research
, 26
(6)
pp. 1220-1228.
10.1158/1078-0432.CCR-19-2962.
|
Houlihan, CF;
Vora, N;
Byrne, T;
Lewer, D;
Kelly, G;
Heaney, J;
Gandhi, S;
... SAFER Investigators; + view all
(2020)
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
The Lancet
, 396
(10246)
e6-e7.
10.1016/S0140-6736(20)31484-7.
|
Howie, Alexander J;
Owen-Casey, Mared P;
(2020)
"Green/apple-green birefringence": unfit for purpose?
Kidney International
, 98
(5)
p. 1350.
10.1016/j.kint.2020.07.029.
|
Hudeček, J;
Voorwerk, L;
van Seijen, M;
Nederlof, I;
de Maaker, M;
van den Berg, J;
van de Vijver, KK;
... Peale, F; + view all
(2020)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
npj Breast Cancer
, 6
, Article 15. 10.1038/s41523-020-0155-1.
|
Jamieson, L;
Forster, MD;
Zaki, K;
Mitra, S;
Alli, H;
O’Connor, A;
Patel, A;
... Chambers, PC; + view all
(2020)
Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study.
BMC Cancer
, 20
, Article 743. 10.1186/s12885-020-07215-3.
|
Joharatnam-Hogan, N;
Hochhauser, D;
Shiu, K-K;
Rush, H;
Crolley, V;
Wilson, W;
Sharma, A;
... Khan, K; + view all
(2020)
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Therapeutic Advances in Medical Oncology
pp. 1-9.
10.1177/1758835920956803.
|
Joharatnam-Hogan, N;
Shiu, KK;
Khan, K;
(2020)
Challenges in the treatment of gastric cancer in the older patient.
Cancer Treatment Reviews
, 85
, Article 101980. 10.1016/j.ctrv.2020.101980.
|
Joharatnam-Hogan, N;
Wilson, W;
Shiu, KK;
Fusai, GK;
Davidson, B;
Hochhauser, D;
Bridgewater, J;
(2020)
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience.
Cancers
, 12
(12)
, Article 3545. 10.3390/cancers12123545.
|
Jones, M;
Beuron, F;
Borg, A;
Nans, A;
Earl, CP;
Briggs, DC;
Snijders, AP;
... McDonald, NQ; + view all
(2020)
Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.
Nature Communications
, 11
(1)
, Article 1120. 10.1038/s41467-020-14856-2.
|
Jones, S;
King, PJ;
Antonescu, CN;
Sugiyama, MG;
Bhamra, A;
Surinova, S;
Angelopoulos, N;
... Hochhauser, D; + view all
(2020)
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.
Scientific Reports
, 10
, Article 663. 10.1038/s41598-019-57153-9.
|
Kelley, RK;
Meyer, T;
Rimassa, L;
Merle, P;
Park, J-W;
Yau, T;
Chan, SL;
... Abou-Alfa, GK; + view all
(2020)
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Clinical Cancer Research
, 26
(18)
pp. 4795-4804.
10.1158/1078-0432.CCR-19-3884.
|
Kelley, RK;
Ryoo, B-Y;
Merle, P;
Park, J-W;
Bolondi, L;
Chan, SL;
Lim, HY;
... Abou-Alfa, GK; + view all
(2020)
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.
ESMO Open
, 5
(4)
, Article e000714. 10.1136/esmoopen-2020-000714.
|
Khalil, AME;
Memon, FA;
Tabish, TA;
Salmon, D;
Zhang, S;
Butler, D;
(2020)
Nanostructured porous graphene for efficient removal of emerging contaminants (pharmaceuticals) from water.
Chemical Engineering Journal
, 398
, Article 125440. 10.1016/j.cej.2020.125440.
|
Kong, A;
Good, J;
Kirkham, A;
Savage, J;
Mant, R;
Llewellyn, L;
Parish, J;
... Mehanna, H; + view all
(2020)
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol.
BMJ Open
, 10
(3)
, Article e033009. 10.1136/bmjopen-2019-033009.
|
Kos, Z;
Roblin, E;
Kim, RS;
Michiels, S;
Gallas, BD;
Chen, W;
van de Vijver, KK;
... International Immuno-Oncology Biomarker Working Group; + view all
(2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ Breast Cancer
, 6
, Article 17. 10.1038/s41523-020-0156-0.
|
Kristeleit, R;
Evans, J;
Molife, LR;
Tunariu, N;
Shaw, H;
Slater, S;
Haris, NRM;
... Lopez, J; + view all
(2020)
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
British Journal of Cancer
10.1038/s41416-020-1010-8.
(In press).
|
Kurzrock, R;
Bowles, DW;
Kang, H;
Meric-Bernstam, F;
Hainsworth, J;
Spigel, DR;
Bose, R;
... Swanton, C; + view all
(2020)
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Annals of Oncology
, 31
(3)
pp. 412-421.
10.1016/j.annonc.2019.11.018.
|
Labeur, TA;
Berhane, S;
Edeline, J;
Blanc, J-F;
Bettinger, D;
Meyer, T;
Van Vugt, JLA;
... Johnson, PJ; + view all
(2020)
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
Liver International
, 40
(1)
pp. 215-228.
10.1111/liv.14270.
|
Ladenstein, R;
Pötschger, U;
Valteau-couanet, D;
Luksch, R;
Castel, V;
Ash, S;
Laureys, G;
... Lode, HN; + view all
(2020)
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1).
Cancers
, 12
(2)
, Article 309. 10.3390/cancers12020309.
|
Lai, AG;
Pasea, L;
Banerjee, A;
Hall, G;
Denaxas, S;
Chang, WH;
Katsoulis, M;
... Hemingway, H; + view all
(2020)
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
BMJ Open
, 10
(11)
, Article e043828. 10.1136/bmjopen-2020-043828.
|
Lauder, SN;
Smart, K;
Kersemans, V;
Allen, D;
Scott, J;
Pires, A;
Milutinovic, S;
... Gallimore, A; + view all
(2020)
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3.
Journal for Immuno Therapy of Cancer
, 8
(2)
, Article e000693. 10.1136/jitc-2020-000693.
|
Lechner, M;
Liu, J;
Lund, VJ;
(2020)
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.
Current Oncology Reports
, 22
(10)
10.1007/s11912-020-00947-2.
|
Lechner, M;
Sutton, L;
Murkin, C;
Masterson, L;
O'Flynn, P;
Wareing, MJ;
Tatla, T;
(2020)
Squamous cell cancer of the temporal bone: a review of the literature.
European Archives of Oto-Rhino-Laryngology
10.1007/s00405-020-06281-4.
|
Lee, A;
(2020)
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer.
Cancer Discovery
, 10
(10)
pp. 1465-1474.
10.1158/2159-8290.CD-20-0773.
|
Lee, A;
Waterhouse, J;
Linch, M;
(2020)
Changing Paradigms in the Treatment of Advanced Urothelial Carcinoma: A 2020 Update.
EMJ Oncology
, 8
(3)
10.33590/emj/20-00044.
|
Lee, LYW;
Cazier, J-B;
Starkey, T;
Briggs, SEW;
Arnold, R;
Bisht, V;
Booth, S;
... UK Coronavirus Cancer Monitoring Project Team; + view all
(2020)
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
The Lancet Oncology
, 21
(10)
pp. 1309-1316.
10.1016/S1470-2045(20)30442-3.
|
Lee, LYW;
Cazier, JB;
Starkey, T;
Turnbull, CD;
Kerr, R;
Middleton, G;
(2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
The Lancet
, 395
(10241)
pp. 1919-1926.
10.1016/S0140-6736(20)31173-9.
|
Lee, W-C;
Reuben, A;
Hu, X;
McGranahan, N;
Chen, R;
Jalali, A;
Negrao, MV;
... Zhang, J; + view all
(2020)
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
Genome Biology
, 21
(1)
, Article 271. 10.1186/s13059-020-02175-0.
|
Leon, TE;
Rapoz-D'Silva, T;
Bertoli, C;
Rahman, S;
Magnussen, M;
Philip, B;
Farah, N;
... Mansour, MR; + view all
(2020)
EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress.
Cancer Discovery
, 10
(7)
10.1158/2159-8290.CD-19-0789.
|
Leone, G;
Passiglia, F;
Bironzo, P;
Bertaglia, V;
Novello, S;
(2020)
Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer? -a literature review.
Translational Lung Cancer Research
, 9
(6)
pp. 2674-2685.
10.21037/tlcr-20-710.
|
Levitt, JA;
Poland, SP;
Krstajic, N;
Pfisterer, K;
Erdogan, A;
Barber, PR;
Parsons, M;
... Ameer-Beg, SM; + view all
(2020)
Quantitative real-time imaging of intracellular FRET biosensor dynamics using rapid multi-beam confocal FLIM.
Scientific Reports
, 10
, Article 5146. 10.1038/s41598-020-61478-1.
|
Li, BT;
Michelini, F;
Misale, S;
Cocco, E;
Baldino, L;
Cai, Y;
Shifman, S;
... Scaltriti, M; + view all
(2020)
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Cancer Discovery
, 10
(5)
pp. 674-687.
10.1158/2159-8290.cd-20-0215.
|
Lidington, EK;
Smrke, A;
Ingley, KM;
Strauss, SJ;
Husson, O;
Younger, E;
(2020)
Cancer care and well-being in adolescents and young adults during the coronavirus disease 2019 pandemic: A UK sarcoma perspective.
Cancer
, 126
(24)
pp. 5359-5360.
10.1002/cncr.33215.
|
Lieverse, RIY;
Van Limbergen, EJ;
Oberije, CJG;
Troost, EGC;
Hadrup, SR;
Dingemans, A-MC;
Hendriks, LEL;
... Lambin, P; + view all
(2020)
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
BMC Cancer
, 20
, Article 557. 10.1186/s12885-020-07055-1.
|
Linch, M;
Lee, A;
(2020)
Positioning checkpoint blockade in urothelial cancer: PURE-01 and PEANUTS.
Annals of Oncology
, 31
(12)
pp. 1601-1602.
10.1016/j.annonc.2020.10.468.
|
Litchfield, K;
Reading, JL;
Lim, EL;
Xu, H;
Liu, P;
Al-Bakir, M;
Wong, YNS;
... Swanton, C; + view all
(2020)
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature Communications
, 11
, Article 3800. 10.1038/s41467-020-17526-5.
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
Liu, MC;
Oxnard, GR;
Klein, EA;
Swanton, C;
Seiden, MV;
CCGA Consortium, .;
(2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Annals of Oncology
, 31
(6)
pp. 745-759.
10.1016/j.annonc.2020.02.011.
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
Loveday, C;
Litchfield, K;
Proszek, PZ;
Cornish, AJ;
Santo, F;
Levy, M;
Macintyre, G;
... Turnbull, C; + view all
(2020)
Genomic landscape of platinum resistant and sensitive testicular cancers.
Nature Communications
, 11
, Article 2189. 10.1038/s41467-020-15768-x.
|
Luszczak, S;
Kumar, C;
Sathyadevan, VK;
Simpson, BS;
Gately, KA;
Whitaker, HC;
Heavey, S;
(2020)
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Signal Transduction and Targeted Therap
, 5
(1)
, Article 7. 10.1038/s41392-020-0109-y.
|
Luszczak, S;
Simpson, BS;
Stopka-Farooqui, U;
Sathyadevan, VK;
Echeverria, LMC;
Kumar, C;
Costa, H;
... Heavey, S; + view all
(2020)
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
[Corrigendum].
Scientific Reports
, 10
, Article 19870. 10.1038/s41598-020-76679-x.
|
Luszczak, S;
Simpson, BS;
Stopka-Farooqui, U;
Sathyadevan, VK;
Echeverria, LMC;
Kumar, C;
Costa, H;
... Heavey, S; + view all
(2020)
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Scientific Reports
, 10
, Article 14380. 10.1038/s41598-020-71263-9.
|
Madsen, RR;
(2020)
PI3K in stemness regulation: from development to cancer.
Biochemical Society Transactions
, 2020
, Article BST20190778. 10.1042/BST20190778.
|
Madsen, RR;
Vanhaesebroeck, B;
(2020)
Cracking the context-specific PI3K signaling code.
Science Signaling
, 13
(613)
, Article eaay2940. 10.1126/scisignal.aay2940.
|
Matharu, RK;
Tabish, TA;
Trakoolwilaiwan, T;
Mansfield, J;
Moger, J;
Wu, T;
Lourenço, C;
... Edirisinghe, M; + view all
(2020)
Microstructure and antibacterial efficacy of graphene oxide nanocomposite fibres.
Journal of Colloid and Interface Science
, 571
pp. 239-252.
10.1016/j.jcis.2020.03.037.
|
McLeavy, L;
Rahman, B;
Kristeleit, R;
Ledermann, J;
Lockley, M;
McCormack, M;
Mould, T;
... Lanceley, A; + view all
(2020)
Mainstreamed Genetic Testing in Ovarian Cancer: Patient Experience of the Testing Process.
International Journal of Gynecological Cancer
, 30
(2)
pp. 221-226.
10.1136/ijgc-2019-000630.
|
Mehanna, H;
Rischin, D;
Wong, SJ;
Gregoire, V;
Ferris, R;
Waldron, J;
Le, Q-T;
... Porceddu, S; + view all
(2020)
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.
Journal of Clinical Oncology
, 38
(22)
pp. 2552-2557.
10.1200/JCO.20.00056.
|
Middleton, G;
Fletcher, P;
Popat, S;
Savage, J;
Summers, Y;
Greystoke, A;
Gilligan, D;
... Billingham, L; + view all
(2020)
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature
, 583
(7818)
pp. 807-812.
10.1038/s41586-020-2481-8.
|
Montagner, M;
Bhome, R;
Hooper, S;
Chakravarty, P;
Qin, X;
Sufi, J;
Bhargava, A;
... Sahai, E; + view all
(2020)
Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination.
Nature Cell Biology
, 22
pp. 289-296.
10.1038/s41556-020-0474-3.
|
Moore, KM;
Desai, A;
Delgado, BDL;
Trabulo, SMD;
Reader, C;
Brown, NF;
Murray, ER;
... Marshall, JF; + view all
(2020)
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
Theranostics
, 10
(7)
pp. 2930-2942.
10.7150/thno.38702.
|
Morales Torres, C;
Wu, MY;
Hobor, S;
Wainwright, EN;
Martin, MJ;
Patel, H;
Grey, W;
... Scaffidi, P; + view all
(2020)
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis.
Nature Communications
, 11
(1)
, Article 1792. 10.1038/s41467-020-15615-z.
|
Morschhauser, F;
Machiels, J-P;
Salles, G;
Rottey, S;
Rule, SAJ;
Cunningham, D;
Peyrade, F;
... Awada, A; + view all
(2020)
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Molecular Cancer Therapeutics
, 19
(2)
pp. 468-478.
10.1158/1535-7163.MCT-19-0466.
|
Munkhbaatar, E;
Dietzen, M;
Agrawal, D;
Anton, M;
Jesinghaus, M;
Boxberg, M;
Pfarr, N;
... Jost, PJ; + view all
(2020)
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Nature Communications
, 11
(1)
, Article 4527. 10.1038/s41467-020-18372-1.
|
Nannini, F;
Parekh, F;
Wawrzyniecka, P;
Mekkaoui, L;
Righi, M;
Dastjerdi, FV;
Yeung, J;
... Pule, M; + view all
(2020)
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.
Scientific Reports
, 10
, Article 19168. 10.1038/s41598-020-76069-3.
|
Ng, KW;
Faulkner, N;
Cornish, GH;
Rosa, A;
Harvey, R;
Hussain, S;
Ulferts, R;
... Kassiotis, G; + view all
(2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science
, Article eabe1107. 10.1126/science.abe1107.
(In press).
|
Nordstrom, BL;
Oguz, M;
Chu, BC;
Ouwens, M;
Arkenau, H-T;
Klein, AB;
(2020)
Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparison.
Journal of Comparative Effectiveness Research
, 9
(3)
pp. 191-199.
10.2217/cer-2019-0163.
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: High Gleason Grade and Increased Tumour Volume are Not the Only Important Histopathological Features.
BJU International
, 126
(2)
pp. 237-239.
10.1111/bju.15085.
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Ball, R;
Freeman, A;
Kelly, D;
Kirkham, A;
... Emberton, M; + view all
(2020)
Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.
BMJ Open
, 10
(10)
, Article e039735. 10.1136/bmjopen-2020-039735.
|
Norris, JM;
Simpson, BS;
Freeman, A;
Kirkham, A;
Whitaker, HC;
Emberton, M;
(2020)
Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis.
The FASEB Journal
, 34
pp. 14150-14159.
10.1096/fj.202001466R.
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.
European Urology Open Science
, 20
pp. 37-47.
10.1016/j.euros.2020.06.006.
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis.
BMJ Open
, 10
(1)
, Article e034611. 10.1136/bmjopen-2019-034611.
|
Norris, JM;
Simpson, BS;
Parry, MA;
Kasivisvanathan, V;
Allen, C;
Ball, R;
Freeman, A;
... Emberton, M; + view all
(2020)
Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It's time to take stock.
BJU International
, 125
(3)
pp. 340-342.
10.1111/bju.14919.
|
O'Connor, E;
Simpson, BS;
Houlden, H;
Vandrovcova, J;
Matharu, M;
(2020)
Prevalence of familial cluster headache: a systematic review and meta-analysis.
The Journal of Headache and Pain
, 21
, Article 37. 10.1186/s10194-020-01101-w.
|
O'Donnell, PH;
Arkenau, HT;
Sridhar, SS;
Ong, M;
Drakaki, A;
Spira, A;
Zhang, J;
... Friedlander, T; + view all
(2020)
Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108.
Cancer
, 126
(2)
pp. 432-443.
10.1002/cncr.32532.
|
Orgaz, JL;
Crosas-Molist, E;
Sadok, A;
Perdrix-Rosell, A;
Maiques, O;
Rodriguez-Hernandez, I;
Monger, J;
... Sanz-Moreno, V; + view all
(2020)
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.
Cancer Cell
, 37
(1)
85-103.e9.
10.1016/j.ccell.2019.12.003.
|
Oza, AM;
Matulonis, UA;
Alvarez Secord, A;
Nemunaitis, J;
Roman, LD;
Blagden, SP;
Banerjee, S;
... Matei, D; + view all
(2020)
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Clinical Cancer Research
, 26
(5)
pp. 1009-1016.
10.1158/1078-0432.CCR-19-1638.
|
Patel, P;
Alrifai, D;
McDonald, F;
Forster, M;
(2020)
Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited).
British Journal of Cancer
, 123
pp. 18-27.
10.1038/s41416-020-01071-5.
|
Pennycuick, A;
Teixeira, VH;
AbdulJabbar, K;
Raza, SEA;
Lund, T;
Akarca, AU;
Rosenthal, R;
... Janes, SM; + view all
(2020)
Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer.
Cancer Discovery
, 10
(10)
pp. 1489-1499.
10.1158/2159-8290.CD-19-1366.
|
Perez-Gracia, JL;
Awada, A;
Calvo, E;
Amaral, T;
Arkenau, H-T;
Gruenwald, V;
Bodoky, G;
... Douillard, J-Y; + view all
(2020)
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.
ESMO Open
, 5
(3)
, Article e000662. 10.1136/esmoopen-2019-000662.
|
Perry, N;
Moss, S;
Dixon, S;
Milner, S;
Mokbel, K;
Lemech, C;
Arkenau, H-T;
... Pinker, K; + view all
(2020)
Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors.
Diagnostics
, 10
(6)
, Article 418. 10.3390/diagnostics10060418.
|
Pettitt, SJ;
Frankum, JR;
Punta, M;
Lise, S;
Alexander, J;
Chen, Y;
Yap, TA;
... Lord, CJ; + view all
(2020)
Clinical brca1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance.
Cancer Discovery
, 10
(10)
pp. 1475-1488.
10.1158/2159-8290.CD-19-1485.
|
Pickles, OJ;
Lee, LYW;
Starkey, T;
Freeman-Mills, L;
Olsson-Brown, A;
Cheng, V;
Hughes, DJ;
... Middleton, G; + view all
(2020)
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
British Journal of Cancer
, 123
pp. 691-693.
10.1038/s41416-020-0930-7.
|
Pinato, DJ;
Lee, AJX;
Biello, F;
Seguí, E;
Aguilar-Company, J;
Carbó, A;
Bruna, R;
... Gennari, A; + view all
(2020)
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
Cancers
, 12
(7)
, Article 1841. 10.3390/cancers12071841.
|
Prendergast, SC;
Strobl, A-C;
Cross, W;
Pillay, N;
Strauss, SJ;
Ye, H;
Lindsay, D;
... Amary, F; + view all
(2020)
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
The Journal of Pathology: Clinical Research
10.1002/cjp2.174.
(In press).
|
Przewrocka, J;
Rowan, A;
Rosenthal, R;
Kanu, N;
Swanton, C;
(2020)
Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting.
Annals of Oncology
, 31
(9)
pp. 1270-1273.
10.1016/j.annonc.2020.04.480.
|
Qin, X;
Tape, CJ;
(2020)
Deciphering Organoids: High-Dimensional Analysis of Biomimetic Cultures.
Trends in Biotechnology
, 39
(8)
pp. 774-787.
10.1016/j.tibtech.2020.10.013.
|
Qin, X;
Sufi, J;
Vlckova, P;
Kyriakidou, P;
Acton, SE;
Li, VSW;
Nitz, M;
(2020)
Cell-type-specific signaling networks in heterocellular organoids.
Nature Methods
, 17
pp. 335-342.
10.1038/s41592-020-0737-8.
|
Reale, ML;
Bironzo, P;
Bertaglia, V;
Palesandro, E;
Leone, G;
Tabbò, F;
Bungaro, M;
... Novello, S; + view all
(2020)
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.
Frontiers in Oncology
, 10
, Article 1722. 10.3389/fonc.2020.01722.
|
Rodríguez-Galán, O;
García-Gómez, JJ;
Rosado, IV;
Wei, W;
Méndez-Godoy, A;
Pillet, B;
Alekseenko, A;
... de la Cruz, J; + view all
(2020)
A functional connection between translation elongation and protein folding at the ribosome exit tunnel in Saccharomyces cerevisiae.
Nucleic Acids Research
10.1093/nar/gkaa1200.
(In press).
|
Rodríguez-Martínez, M;
Boissiére, T;
Gonzalez, MN;
Litchfield, K;
Mitter, R;
Walker, J;
Kjœr, S;
... Svejstrup, JQ; + view all
(2020)
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver.
Cell
, 181
(6)
1395-1405.e11.
10.1016/j.cell.2020.04.014.
|
Sadeqi Azer, E;
Rashidi Mehrabadi, F;
Malikić, S;
Li, XC;
Bartok, O;
Litchfield, K;
Levy, R;
... Sahinalp, SC; + view all
(2020)
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem.
Bioinformatics
, 36
(S1)
i169-i176.
10.1093/bioinformatics/btaa464.
|
Sangro, B;
Chan, SL;
Meyer, T;
Reig, M;
El-Khoueiry, A;
Galle, PR;
(2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.
Journal of Hepatology
, 72
(2)
pp. 320-341.
10.1016/j.jhep.2019.10.021.
|
Sarker, D;
Plummer, R;
Meyer, T;
Sodergren, M;
Basu, B;
Chee, CE;
Huang, K-W;
... Habib, N; + view all
(2020)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Clinical Cancer Research
, 26
(15)
pp. 3936-3946.
10.1158/1078-0432.CCR-20-0414.
|
Schenk, A;
López, S;
Kschischo, M;
McGranahan, N;
(2020)
Germline ancestry influences the evolutionary disease course in lung adenocarcinomas.
Evolutionary Applications
10.1111/eva.12964.
|
Schmid, P;
Abraham, J;
Chan, S;
Wheatley, D;
Brunt, AM;
Nemsadze, G;
Baird, RD;
... Turner, NC; + view all
(2020)
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
Journal of Clinical Oncology
, 38
(5)
pp. 423-433.
10.1200/JCO.19.00368.
|
Simpson, BS;
Camacho, N;
Luxton, HJ;
Pye, H;
Finn, R;
Heavey, S;
Pitt, J;
... Whitaker, HC; + view all
(2020)
Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
Communications Biology
, 3
(1)
, Article 440. 10.1038/s42003-020-01175-x.
|
Sng, CCT;
Wong, YNS;
Wu, A;
Ottaviani, D;
Chopra, N;
Galazi, M;
Benafif, S;
... Shaw, H; + view all
(2020)
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.
Frontiers in Oncology
, 10
, Article 595804. 10.3389/fonc.2020.595804.
|
Stark, A-K;
Davenport, ECM;
Patton, DT;
Scudamore, CL;
Vanhaesebroeck, B;
Veldhoen, M;
Garden, OA;
(2020)
Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
The Journal of Immunology
10.4049/jimmunol.2000043.
(In press).
|
Sud, A;
Jones, M;
Broggio, J;
Loveday, C;
Torr, B;
Garrett, A;
Nicol, DL;
... Turnbull, C; + view all
(2020)
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
Annals of Oncology
10.1016/j.annonc.2020.05.009.
(In press).
|
Sud, A;
Torr, B;
Jones, ME;
Broggio, J;
Scott, S;
Loveday, C;
Garrett, A;
... Turnbull, C; + view all
(2020)
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
The Lancet Oncology
, 21
(8)
pp. 1035-1044.
10.1016/S1470-2045(20)30392-2.
|
Sullivan, R;
Heavey, S;
Graham, DG;
Wellman, R;
Khan, S;
Thrumurthy, S;
Simpson, BS;
... Lovat, LB; + view all
(2020)
An optimised saliva collection method to produce high-yield, high-quality RNA for translational research.
PLOS ONE
, 15
(3)
, Article e0229791. 10.1371/journal.pone.0229791.
|
Tabernero, J;
Alsina, M;
Shitara, K;
Doi, T;
Dvorkin, M;
Mansoor, W;
Arkenau, H-T;
... Ilson, DH; + view all
(2020)
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Gastric Cancer
10.1007/s10120-020-01053-9.
|
Tabish, TA;
Hamblin, MR;
(2020)
Multivalent nanomedicines to treat COVID-19: A slow train coming.
Nano Today
, 35
, Article 100962. 10.1016/j.nantod.2020.100962.
|
Tabish, TA;
Narayan, RJ;
Edirisinghe, M;
(2020)
Rapid and label-free detection of COVID-19 using coherent anti-Stokes Raman scattering microscopy.
MRS Communications
, 10
(4)
pp. 566-572.
10.1557/mrc.2020.81.
|
Terwisscha van Scheltinga, SEJ;
Wijnen, MHWA;
Martelli, H;
Rogers, T;
Mandeville, H;
Gaze, MN;
McHugh, K;
... Merks, HHM; + view all
(2020)
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study.
Cancer Medicine
, 9
(20)
pp. 7580-7589.
10.1002/cam4.3365.
|
The UK Coronavirus Cancer Monitoring Project team;
(2020)
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19.
The Lancet Oncology
, 21
(5)
pp. 622-624.
10.1016/S1470-2045(20)30230-8.
|
Therond, C;
Lanceley, A;
Gibbon, S;
Rahman, B;
(2020)
The narrative paradox of the BRCA gene: An ethnographic study in the clinical encounters of ovarian cancer patients.
Anthropology & Medicine
, 27
(4)
pp. 449-464.
10.1080/13648470.2019.1663784.
|
van der Noll, R;
Jager, A;
Ang, JE;
Marchetti, S;
Mergui-Roelvink, MWJ;
de Bono, JS;
Lolkema, MP;
... Schellens, JHM; + view all
(2020)
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
Investigational New Drugs
, 38
pp. 1096-1107.
10.1007/s10637-019-00857-6.
|
van der Noll, R;
Jager, A;
Ang, JE;
Marchetti, S;
Mergui-Roelvink, MWJ;
Lolkema, MP;
de Jonge, MJA;
... Schellens, JHM; + view all
(2020)
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
Investigational New Drugs
, 38
pp. 1117-1128.
10.1007/s10637-019-00856-7.
|
Walls, GM;
Oughton, JB;
Chalmers, AJ;
Brown, S;
Collinson, F;
Forster, MD;
Franks, KN;
... Greystoke, A; + view all
(2020)
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clinical and Translational Radiation Oncology
, 25
pp. 61-66.
10.1016/j.ctro.2020.09.006.
|
Waterhouse, JV;
Hull, JH;
Linch, M;
(2020)
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
European Urology
10.1016/j.eururo.2020.04.027.
(In press).
|
Watkins, TBK;
Lim, EL;
Petkovic, M;
Elizalde, S;
Birkbak, NJ;
Wilson, GA;
Moore, DA;
... Swanton, C; + view all
(2020)
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
, 587
pp. 126-132.
10.1038/s41586-020-2698-6.
|
Wilcz-Villega, E;
Carter, E;
Ironside, A;
Xu, R;
Mataloni, I;
Holdsworth, J;
Jones, W;
... Bianchi, K; + view all
(2020)
Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway.
EMBO Molecular Medicine
, Article e10491. 10.15252/emmm.201910491.
(In press).
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Platé, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2020)
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
[Corrigendum].
Nature Communications
, 11
, Article 4680. 10.1038/s41467-020-18621-3.
|
Wu, A;
Cremaschi, P;
Wetterskog, D;
Conteduca, V;
Franceschini, GM;
Kleftogiannis, D;
Jayaram, A;
... Attard, G; + view all
(2020)
Genome-wide plasma DNA methylation features of metastatic prostate cancer.
Journal of Clinical Investigation
, 130
(4)
pp. 1991-2000.
10.1172/JCI130887.
|
Wu, W;
Zhou, G;
Han, H;
Huang, X;
Jiang, H;
Mukai, S;
Kazlauskas, A;
... Lei, H; + view all
(2020)
PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.
Diabetes
, 69
(4)
pp. 739-748.
10.2337/db19-0713.
|
Xu, R;
Jones, W;
Wilcz-Villega, E;
Costa, AS;
Rajeeve, V;
Bentham, RB;
Bryson, K;
... Bianchi, K; + view all
(2020)
The breast cancer oncogene IKKε coordinates mitochondrial function and serine metabolism.
EMBO Reports
, Article e48260. 10.15252/embr.201948260.
|
Yoshida, K;
Gowers, KHC;
Lee-Six, H;
Chandrasekharan, DP;
Coorens, T;
Maughan, EF;
Beal, K;
... Campbell, PJ; + view all
(2020)
Tobacco smoking and somatic mutations in human bronchial epithelium.
Nature
, 578
pp. 266-272.
10.1038/s41586-020-1961-1.
|
Younger, E;
Smrke, A;
Lidington, E;
Farag, S;
Ingley, K;
Chopra, N;
Maleddu, A;
... Jones, RL; + view all
(2020)
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic.
Cancers
, 12
(8)
, Article 2288. 10.3390/cancers12082288.
|
Zhai, H;
Moore, D;
Jamal-Hanjani, M;
(2020)
Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma.
Annals of Oncology
, 31
(2)
pp. 169-170.
10.1016/j.annonc.2019.12.004.
|
Conference item
Kotsiou, E;
Hou, TZ;
Robinson, J;
Varsani, S;
Oakes, T;
Becker, PD;
Patel, S;
... Newton, K; + view all
(2020)
Next generation clonal neoantigen targeting T cells, generated using the PELEUS (TM) bioinformatics platform and the VELOS (TM) manufacturing method show superior reactivity and phenotypic characteristics than classical TIL products.
Presented at: AACR Annual Meeting, Philadelphia, PA, USA.
|
Thesis
Al Bakir, Maise;
(2020)
The Evolution of Metastases in Non-Small Cell Lung Cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
Jones, Morgan Llewellyn;
(2020)
Structural and functional analysis of the human XPF-ERCC1 DNA repair endonuclease.
Doctoral thesis (Ph.D), UCL (University College London).
|